Airway Pressure During Humidified High Flow Nasal Cannula Therapy in Children
1 other identifier
observational
40
1 country
1
Brief Summary
Humidified High Flow Nasal Cannula (HHFNC) is a new modality of respiratory support for children with respiratory failure. Despite its extensive use in pediatric and adult population, the exact mechanism of work of HHFNC is not fully explained.The objective of the investigators' research project is to determine the relationship between the amount of airway pressure that can be delivered at specific flow levels of HHFNC. This information will allow the investigators to use HHFNC in a much more informed and safe manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2015
CompletedFirst Posted
Study publicly available on registry
March 13, 2015
CompletedStudy Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedMarch 6, 2019
November 1, 2015
1.5 years
March 8, 2015
March 5, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Airway pressure measurement
oesophageal pressure will be measured as a surrogate of airway pressure using Nasogastric tube liquid filled technique.
will be measured at start of HHFNC therapy and with titration of flow rate.
Secondary Outcomes (1)
predictors of positive airway pressure delivery.
will be measured simultaneously with airway pressure
Eligibility Criteria
Children under 18 years, admitted to PCCU, who require respiratory support using HHFNC, as determined by the caring physician; and informed consent of substitute decision maker will be included in the study.
You may qualify if:
- Aged less than 18 years, admitted to PCCU with acute respiratory distress.
- HHFNC respiratory support prescribed by the caring physician.
- Requirement for a size 10 French or smaller nasogastric (NG) or orogastric (OG) tube, as prescribed by the caring physician.
- Informed consent, and/- or assent where appropriate.
You may not qualify if:
- Continuous or intermittent NG or OG tube suction is required.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
McMaster Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Choong, FRCP(C)
McMaster University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 8, 2015
First Posted
March 13, 2015
Study Start
June 1, 2015
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
March 6, 2019
Record last verified: 2015-11